Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda

JA Ndahimana, DJ Riedel… - Tropical Medicine & …, 2016 - Wiley Online Library
Objective To evaluate HIV drug resistance ( HIVDR ) and determinants of virological failure
in a large cohort of patients receiving first‐line tenofovir‐based antiretroviral therapy ( ART ) …

[HTML][HTML] Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration

…, B Kerschberger, VC Marconi, JD Ndahimana… - …, 2017 - thelancet.com
Tenofovir disoproxil fumarate (TDF) genotypic resistance defined by K65R/N and/or K70E/Q/G
occurs in 20% to 60% of individuals with virological failure (VF) on a WHO-recommended …

[HTML][HTML] Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study

I Kamali, DA Barnhart, JA Ndahimana, K Noor… - PloS one, 2021 - journals.plos.org
Introduction As part of the integration of refugees into Rwanda’s national hepatitis C elimination
agenda, a mass screening campaign for hepatitis B (HBV) and hepatitis C (HCV) was …

[HTML][HTML] A cost analysis of the diagnosis and treatment of malaria at public health facilities and communities in three districts in Rwanda

O Masimbi, JM Schurer, E Rafferty, JDA Ndahimana… - Malaria Journal, 2022 - Springer
Background Malaria is a potentially fatal disease spread by the bites of Plasmodium-infected
Anopheles mosquitoes. Despite long-term efforts to control malaria in Rwanda, malaria …

[HTML][HTML] Initiation of hepatitis C treatment in two rural Rwandan districts: a mobile clinic approach

…, J Serumondo, F Kateera, J d'Amour Ndahimana - BMC infectious …, 2021 - Springer
Background To eliminate hepatitis C, Rwanda is conducting national mass screenings and
providing to people with chronic hepatitis C free access to Direct Acting Antivirals (DAAs). …

[HTML][HTML] Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study

…, G Nshogoza Rwibasira, JA Ndahimana - BMC Infectious …, 2022 - Springer
Background Since the discovery of direct-acting antivirals, treatment for hepatitis C virus (HCV)
is increasingly accessible in low-resource settings, but quality of care in these settings is …

HIV drug resistance mutations among patients failing second-line antiretroviral therapy in Rwanda

JA Ndahimana, DJ Riedel, R Muhayimpundu… - 2016 - journals.sagepub.com
Background Studies of patients failing second-line antiretroviral therapy (ART) in resource-limited
settings (RLS) are few. Evidence suggests most patients who appear to be …

Time to initiation of antiretroviral therapy among patients who are ART eligible in Rwanda: improvement over time

…, C Wang, U Francois, JA Ndahimana… - JAIDS Journal of …, 2015 - journals.lww.com
Background: Delayed initiation of antiretroviral therapy (ART) in eligible patients is a concern
in resource-limited countries. Methods: We analyzed data on HIV-positive patients≥ 15 …

[HTML][HTML] Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a …

…, J Serumondo, T Ntakirutimana, JA Ndahimana… - BMC Infectious …, 2024 - Springer
Introduction Rwanda’s Hepatitis C elimination campaign has relied on mass screening
campaigns. An alternative “micro-elimination” strategy focused on specific populations, such as …

Implementation and adaptation of a combined economic empowerment and peer support program among youth living with HIV in rural Rwanda

…, AS Goodman, JA Ndahimana… - Journal of the …, 2022 - journals.sagepub.com
Background: Youth living with HIV in rural Rwanda experience poor clinical outcomes. In
2017, we implemented Adolescent Support Groups (ASGs), which provided economic …